PRTK
Paratek Pharmaceuticals Inc.

4,416
Loading...
Loading...
Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based upon tetracycline chemistry. Its products include omadacycline and sarecycline, which are used for the treatment of community-acquired bacterial infections, including community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections and urinary tract infections. The company was founded by Walter Gilbert and Stuart B. Levy in 1996 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Paratek Pharmaceuticals Inc.?
What is the 52-week high for Paratek Pharmaceuticals Inc.?
What is the 52-week low for Paratek Pharmaceuticals Inc.?
What is Paratek Pharmaceuticals Inc. stock price today?
What was Paratek Pharmaceuticals Inc. stock price yesterday?
What is the PE ratio of Paratek Pharmaceuticals Inc.?
What is the Price-to-Book ratio of Paratek Pharmaceuticals Inc.?
What is Paratek Pharmaceuticals Inc.'s EBITDA?
What is the 50-day moving average of Paratek Pharmaceuticals Inc.?

Latest PRTK News

View
No PRTK news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.